patent/WO-0145714-A3

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0145714-A3

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e6947430e0e3b673d72f068a87de145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6e88ed84a8af11c707d7f6847a00ffa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_416767ab092e9c11cec92cb1ff53c356 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
filingDate	2000-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10e8ebbd4e807ee8536980fa88569292 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c31b03abbf3abaab24a9efd48463b89c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94fee63c2aee58b86b602127455a7285
publicationDate	2002-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-0145714-A3
titleOfInvention	Formulations of adenosine a1 agonists
abstract	The present invention provides a method of treating conditions associated with pain and alleviating the symptoms associated therewith which comprises administering to a mammal, including man, (i) an adenosine A1 agonist or a physiologically acceptable salt or solvate thereof and (ii) gabapentin or pregabalin or a physiologically acceptable salt or solvate thereof. The present invention also provides pharmaceutical formulations and patient packs comprising said combinations.
priorityDate	1999-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9819674-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9903473-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3446 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399472 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486971 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399567

Total number of triples: 49.